Updates are available Correction dated 2025-02-12
Click to view Correction: https://doi.org/10.1007/s00134-025-07809-0
-
Authors
Badulak, Jenelle https://orcid.org/0000-0001-9024-1075
Abrams, Darryl
Luks, Andrew M.
Zakhary, Bishoy
Conrad, Steven A.
Bartlett, Robert
MacLaren, Graeme
Vercaemst, Leen
Lorusso, Roberto
Broman, Lars Mikael
Agerstrand, Cara
Price, Susanna
Combes, Alain
Peek, Giles
Fan, Eddy
Shekar, Kiran
Fraser, John
Brodie, Daniel
,
- License Information
-
More Information
Article History
Received: 1 May 2024
Accepted: 2 September 2024
First Online: 18 November 2024
Change Date: 12 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00134-025-07809-0
Declarations
:
: JB is the immediate past chair of the Extracorporeal Life Support Organization (ELSO) Nominations and Membership Committee and a member of the ELSO Education Committee. DB received research support from and consults for LivaNova. He has been on the medical advisory boards for Xenios, Medtronic, Inspira and Cellenkos. He is the President-elect of the ELSO and the Chair of the Executive Committee of the International ECMO Network (ECMONet), and he writes for UpToDate. RB serves on the ELSO Board of Directors. AC receives research funding and personal fees from Getinge, Baxter, and Xenios. RL is a consultant for Medtronic, LivaNova, Xenios and Eurosets, receives personal fees from Abiomed, received research grants from Medtronic and LivaNova, and he is the chair of the ELSO Research Committee. KS receives research support from Queeensland Health and is a member of the Scientific Committee of ECMONet, and Education and Guidelines committees of ELSO. GMacL is the president of ELSO. BZ is the immediate past chair of the ELSO Education Committee. CA writes for UpToDate, and is the immediate past chair of the ELSO Conference Committee. EF reports personal fees from ALung Technologies, Baxter, Getinge, Inspire, Vasomune, and Zoll Medical outside the submitted work, and is the immediate past chair of the ELSO Research Committee. JF has received grants from Xenios, Mera, Fischer and Paykel, and he is co-founder BiVACOR total artificial hearts. LMB is a consultant for Xenios/Fresenius, Eurosets, and HemoCue, and member of EuroELSO Scientific Committee. The remaining authors declare no conflicts of interest and have no financial disclosures. There was no financial support for this study.
